Elucidating the precise pharmacological mechanism of action (MOA) of naturally transpiring compounds can be complicated. Even though Tarselli et al. (sixty) made the 1st de novo synthetic pathway to conolidine and showcased this naturally occurring compound efficiently suppresses responses to both of those chemically induced and inflammation-derive